Head and Neck Cancer Trial, Recruiting NCT07180901 Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07180901
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older.
  • People with a laboratory-confirmed diagnosis of squamous cell carcinoma (a type of cancer) in the mouth or voice box (larynx).
  • People diagnosed between July 2024 and September 2026.
  • People whose treatment plan includes surgery as the main intended treatment.
  • People who may or may not also receive additional treatments after surgery (such as radiation or chemotherapy).
  • People being treated at the Centre Hospitalier de l'Université de Montréal.

Who may not be able to join:

  • People who end up not receiving surgery after all.
  • People whose time between diagnosis/surgery and a key study measurement exceeds 180 days (confirm with trial site for clarification on what "S-PORT" refers to in this context).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Houda Bahig, MD PhD, Centre hospitalier de l'Université de Montréal (CHUM)

Phone: ‭+1 (514) 625-7360‬

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Registry
ClinicalTrials.gov
Start date
21 August 2025
Est. completion
21 October 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Surgery to post-operative radiotherapy time (S-PORT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov